Skip to content
Lower risk Drug recall · FDA · Published September 22, 2023

West-Ward Methotrexate Tablets Recall: Unsmooth Surface and Illegible Labels

West-Ward recalls 2.5 mg methotrexate tablets with unsmooth surfaces and illegible labels. These tablets may not be properly identified or scored, posing risks for patients using prescription medication.

🇺🇸 FDA recall #D-0066-2024DrugWest-Ward ›
Take action

Contact the company

Recalling firmWest-Ward Columbus Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

West-Ward is recalling methotrexate tablets that have unsmooth surfaces and two tablets with illegible identification and scoring. This could lead to incorrect dosing or medication confusion for patients using these prescription drugs. Read more at govinfonow.com/recall/33095-west-ward-methotrexate-tablets-recall-unsmooth-surface-and-illegible-labels.

Source Summary by GovInfoNow · govinfonow.com/recall/33095-west-ward-methotrexate-tablets-recall-unsmooth-surface-and-illegible-labels · Updated August 17, 2026 · FDA enforcement record: FDA #D-0066-2024

Cite this page

“West-Ward Methotrexate Tablets Recall: Unsmooth Surface and Illegible Labels.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33095-west-ward-methotrexate-tablets-recall-unsmooth-surface-and-illegible-labels. Based on FDA recall #D-0066-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0066-2024%22&limit=1).

The FDA announced on Sept. 22, 2023, that West-Ward Columbus Inc is recalling Methotrexate Tablets, USP, 2.5 mg due to failed tablet specifications. The agency stated the recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: West-Ward
  • Product: Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton
  • NDC: 0054-8550-25
  • Lot AB7486B, exp Dec 2023
  • Lot AB8766B, exp April 2024
  • Lot AB9484B, exp Aug 2024
  • Distributed in MS, OH
  • Quantity: 2,673 cartons

The hazard

According to the FDA, the tablets were observed to have an unsmooth surface. Two tablets demonstrated illegible tablet identification and scoring.

Context

GovInfoNow's records show West-Ward Columbus Inc has 8 other recalls on record since May 19, 2016. Recent similar recalls include a Dec. 19, 2024, recall of West-Ward Methadone Tablets for illegible product labels and a July 22, 2020, recall of Leucovorin Calcium Tablets due to labeling errors. Other recent recalls of similar products include an Aug. 19, 2026, American Health Packaging Buprenorphine Tablets recall for label mix-up hazard and a March 16, 2026, Meclizine 12.5mg Tablets recall for failed tablet specifications.

How to tell if you have this one

Check for the lot numbers AB7486B (exp Dec 2023), AB8766B (exp April 2024), or AB9484B (exp Aug 2024) on the packaging. The product is a 2.5 mg methotrexate tablet, 10x10 unit-dose per carton, prescribed only.

  • Brand
    West-Ward
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for lot numbers AB7486B (exp Dec 2023), AB8766B (exp April 2024), or AB9484B (exp Aug 2024) on the packaging.

Where it went and when

Where it was distributed

Distributed in Mississippi and Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: yesMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “MS, OH” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Mississippi, Ohio.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Sep 22, 202312. FDA classified it Class III: Oct 23, 202323. Published in FDA’s Enforcement Report: Nov 1, 202332023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0066-2024 (September 22, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0066-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA